The global telmisartan market was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027. The growth of the global telmisartan ...
The approval covers Apalutamide tablets of 60 mg strength, the company said in a regulatory filing. The drug will be ...
Hindustan Zinc Ltd (HZL) has been fined ₹ 5.37 lakh each by the Bombay Stock Exchange (BSE) and the National Stock Exchange ...
The plan put forth Tuesday could see the Sackler family pay up to $7 billion. Also in the news: Merck prepares to close its manufacturing plant in Pennsylvania; Optum Rx, which includes UnitedHealth ...
On Wednesday, 3018 stocks advanced, 1033 declined and 115 remained unchanged, with an advance decline ratio of 2.92 on the ...
Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...
As per the IQVIA MAT January 2025 data, apalutamide tablets registered annual sales of $1099.80 million in the United States markets.
The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...
On March 18, post-market hours, Zydus Lifesciences announced that it has received approval from the United States Food & Drug ...
The positive trends at GIFT Nifty futures indicate a gap-up opening for Indian equity benchmarks Sensex and Nifty.
Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30 at 1:00 PM when the company ...
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback